Immix Biopharma Stock Price History

IMMX Stock  USD 1.68  0.14  7.69%   
If you're considering investing in Immix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immix Biopharma stands at 1.68, as last reported on the 22nd of November, with the highest price reaching 1.89 and the lowest price hitting 1.65 during the day. Immix Biopharma holds Efficiency (Sharpe) Ratio of -0.0445, which attests that the entity had a -0.0445% return per unit of risk over the last 3 months. Immix Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immix Biopharma's Standard Deviation of 5.47, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.25) to validate the risk estimate we provide.
  
Stock Based Compensation is likely to rise to about 2.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 8.6 M in 2024. . At this time, Immix Biopharma's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 7.68 in 2024, whereas Price To Sales Ratio is likely to drop (0.32) in 2024. Immix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0445

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIMMX

Estimated Market Risk

 5.54
  actual daily
49
51% of assets are more volatile

Expected Return

 -0.25
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Immix Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immix Biopharma by adding Immix Biopharma to a well-diversified portfolio.
Price Book
2.6331
Book Value
0.823
Enterprise Value
27.6 M
Enterprise Value Ebitda
(0.37)
Shares Float
14.5 M

Immix Biopharma Stock Price History Chart

There are several ways to analyze Immix Stock price data. The simplest method is using a basic Immix candlestick price chart, which shows Immix Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceAugust 30, 20242.14
Lowest PriceOctober 3, 20241.34

Immix Biopharma November 22, 2024 Stock Price Synopsis

Various analyses of Immix Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immix Stock. It can be used to describe the percentage change in the price of Immix Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immix Stock.
Immix Biopharma Price Rate Of Daily Change 0.92 
Immix Biopharma Price Daily Balance Of Power(0.58)
Immix Biopharma Price Action Indicator(0.16)

Immix Biopharma November 22, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Immix Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Immix Biopharma intraday prices and daily technical indicators to check the level of noise trading in Immix Stock and then apply it to test your longer-term investment strategies against Immix.

Immix Stock Price History Data

The price series of Immix Biopharma for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 0.94 with a coefficient of variation of 13.36. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.73. The median price for the last 90 days is 1.68.
OpenHighLowCloseVolume
11/22/2024
 1.80  1.89  1.65  1.68 
11/21/2024 1.80  1.89  1.65  1.68  372,923 
11/20/2024 1.70  1.93  1.65  1.82  439,940 
11/19/2024 1.67  1.78  1.65  1.70  91,698 
11/18/2024 1.58  1.80  1.58  1.69  113,368 
11/15/2024 1.61  1.64  1.54  1.59  57,115 
11/14/2024 1.59  1.66  1.57  1.62  36,372 
11/13/2024 1.69  1.74  1.55  1.57  57,786 
11/12/2024 1.76  1.78  1.69  1.72  39,264 
11/11/2024 1.91  1.91  1.75  1.77  70,365 
11/08/2024 1.75  1.95  1.70  1.86  167,627 
11/07/2024 1.56  1.78  1.53  1.75  90,916 
11/06/2024 1.64  1.65  1.57  1.60  91,587 
11/05/2024 1.58  1.60  1.48  1.60  65,563 
11/04/2024 1.57  1.62  1.54  1.58  28,393 
11/01/2024 1.66  1.66  1.55  1.59  29,518 
10/31/2024 1.66  1.66  1.57  1.60  49,001 
10/30/2024 1.66  1.71  1.62  1.65  51,696 
10/29/2024 1.66  1.76  1.63  1.71  78,316 
10/28/2024 1.69  1.77  1.62  1.68  52,726 
10/25/2024 1.60  1.67  1.56  1.66  128,218 
10/24/2024 1.64  1.65  1.58  1.59  40,575 
10/23/2024 1.66  1.66  1.57  1.63  54,336 
10/22/2024 1.58  1.67  1.53  1.65  67,305 
10/21/2024 1.72  1.75  1.58  1.60  83,418 
10/18/2024 1.75  1.79  1.70  1.72  111,030 
10/17/2024 1.46  1.99  1.46  1.69  383,505 
10/16/2024 1.46  1.51  1.39  1.44  99,575 
10/15/2024 1.37  1.54  1.36  1.46  245,870 
10/14/2024 1.46  1.51  1.38  1.38  79,448 
10/11/2024 1.36  1.50  1.36  1.45  70,373 
10/10/2024 1.53  1.55  1.36  1.38  95,859 
10/09/2024 1.53  1.59  1.44  1.54  77,729 
10/08/2024 1.51  1.67  1.49  1.53  209,832 
10/07/2024 1.67  1.80  1.41  1.45  364,163 
10/04/2024 1.34  1.66  1.26  1.63  471,898 
10/03/2024 1.48  1.49  1.32  1.34  179,873 
10/02/2024 1.50  1.51  1.44  1.46  329,418 
10/01/2024 1.47  1.54  1.45  1.48  64,229 
09/30/2024 1.54  1.56  1.43  1.49  161,648 
09/27/2024 1.59  1.59  1.54  1.56  50,524 
09/26/2024 1.62  1.65  1.52  1.59  149,402 
09/25/2024 1.62  1.69  1.60  1.65  57,196 
09/24/2024 1.68  1.72  1.60  1.64  136,393 
09/23/2024 1.79  1.82  1.64  1.68  171,739 
09/20/2024 1.78  1.84  1.74  1.80  96,643 
09/19/2024 1.83  1.87  1.76  1.77  75,120 
09/18/2024 1.82  1.88  1.78  1.78  80,063 
09/17/2024 1.81  1.95  1.81  1.81  87,459 
09/16/2024 1.90  1.95  1.81  1.85  31,500 
09/13/2024 1.87  1.88  1.84  1.86  41,397 
09/12/2024 1.86  1.93  1.81  1.81  39,572 
09/11/2024 1.91  1.91  1.80  1.86  65,667 
09/10/2024 2.02  2.02  1.84  1.90  163,975 
09/09/2024 2.00  2.04  1.94  1.97  45,128 
09/06/2024 2.11  2.14  1.95  1.97  147,521 
09/05/2024 2.03  2.14  2.01  2.10  50,729 
09/04/2024 2.06  2.11  2.01  2.01  50,821 
09/03/2024 2.11  2.19  2.04  2.04  49,072 
08/30/2024 2.11  2.20  2.09  2.14  71,541 
08/29/2024 2.21  2.26  2.10  2.12  39,458 

About Immix Biopharma Stock history

Immix Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immix Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immix Biopharma stock prices may prove useful in developing a viable investing in Immix Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding17.3 M13.1 M
Net Loss-7.4 M-7.8 M

Immix Biopharma Stock Technical Analysis

Immix Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immix Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immix Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Immix Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immix Biopharma's price direction in advance. Along with the technical and fundamental analysis of Immix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.